Heron Therapeutics Inc (HRTX)

Cost of Revenue

$11.57M

Quarterly · Period ending: · USD

HRTX logo

HRTX Cost of Revenue

Latest reported$11.57M
HRTX Quarterly Cost of Revenue ($0.00 → $11.57M)
High-resolution chart · PNG

HRTX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
11,572,000
10,638,000
7,649,000
15,384,000
9,857,000
8,457,000
10,228,000
9,458,000
10,518,000
8,444,000
9,885,000
18,208,000
20,158,000
16,854,000
12,627,000
14,717,000
16,175,000
11,355,000
10,941,000
11,351,000
14,522,000
9,207,000
9,392,000
7,170,000
9,005,000
10,622,000
15,874,000
17,195,000
13,588,000
14,962,000
11,572,000
7,576,000
5,231,000
3,133,000
1,338,000
1,051,000
1,013,000
1,186,000
35,000
30,242,000
27,286,000
16,092,000
16,263,000
14,241,000
16,175,000
14,504,000
12,479,000
14,731,000
14,279,000
11,628,000
6,754,000
6,216,000
10,806,000
7,140,000
5,152,000
3,626,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114,000
109,000
108,000
113,910
146,290
87,341
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.